Science
iRhythm Technologies Sees Insider Trading Activity Amid Ratings Updates
																								
												
												
											Recent updates from brokerages have highlighted changes in the ratings for iRhythm Technologies (NASDAQ: IRTC), a company known for its innovative digital healthcare solutions. Alongside these updates, a series of insider stock transactions have raised interest among investors and analysts.
On August 6, 2023, insider Chad Patterson sold 2,555 shares of the company’s stock at an average price of $158.97. The total value of this transaction reached approximately $406,168.35. Following this sale, Patterson retained 43,667 shares of iRhythm Technologies, valued at nearly $6,941,742.99. This transaction represented a 5.53% decrease in Patterson’s ownership stake in the company.
In another transaction on August 11, 2023, Marc Wade Rosenbaum, the Chief Accounting Officer, sold 226 shares at an average price of $158.93, totaling around $35,918.18. Post-sale, Rosenbaum’s holdings decreased by 2.04% to 10,879 shares, valued at approximately $1,728,999.47. Both transactions were disclosed in filings with the U.S. Securities and Exchange Commission (SEC), which provide transparency regarding insider trading activities.
Over the past ninety days, insiders at iRhythm Technologies have sold a combined total of 43,746 shares valued at approximately $7,081,818. Currently, corporate insiders hold around 1.10% of the company’s total stock.
iRhythm Technologies, headquartered in the United States, specializes in the design, development, and commercialization of device-based technology aimed at providing ambulatory cardiac monitoring services. The company’s flagship product, Zio, offers comprehensive ambulatory monitoring solutions, including both long-term and short-term continuous monitoring, as well as mobile cardiac telemetry services.
As industry analysts continue to evaluate iRhythm’s performance, these insider transactions may reflect broader strategic decisions within the company. Investors often view such activities as indicators of confidence in the company’s future direction and overall market position.
For those interested in keeping up with iRhythm Technologies’ latest news and analyst ratings, MarketBeat.com offers a free daily email newsletter summarizing important updates and insights.
- 
																	
										
																			Science2 weeks agoInventor Achieves Breakthrough with 2 Billion FPS Laser Video
 - 
																	
										
																			Top Stories3 weeks agoCharlie Sheen’s New Romance: ‘Glowing’ with Younger Partner
 - 
																	
										
																			Business3 weeks agoTyler Technologies Set to Reveal Q3 Earnings on October 22
 - 
																	
										
																			Entertainment3 weeks agoDua Lipa Aces GCSE Spanish, Sparks Super Bowl Buzz with Fans
 - 
																	
										
																			Health3 weeks agoCommunity Unites for 7th Annual Into the Light Walk for Mental Health
 - 
																	
										
																			Health3 weeks agoCurium Group, PeptiDream, and PDRadiopharma Launch Key Cancer Trial
 - 
																	
										
																			World3 weeks agoR&B Icon D’Angelo Dies at 51, Leaving Lasting Legacy
 - 
																	
										
																			Entertainment3 weeks agoRed Sox’s Bregman to Become Free Agent; Tigers Commit to Skubal
 - 
																	
										
																			Entertainment3 weeks agoMother Fights to Reunite with Children After Kidnapping in New Drama
 - 
																	
										
																			Health3 weeks agoNorth Carolina’s Biotech Boom: Billions in New Investments
 - 
																	
										
																			Science3 weeks agoNorth Carolina’s Biotech Boom: Billions Invested in Manufacturing
 - 
																	
										
																			Top Stories3 weeks agoDisney+ Launches Chilling Classic ‘Something Wicked’ Just in Time for October
 
